NYMOX PHARMACEUTICAL CORPORATION Adjustments For Finance Costs
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Adjustments For Finance Costs of $28.00 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2023-05-02.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForFinanceCosts · last filed 2023-05-02
| Period end | Adjustments For Finance Costs 12 month | Adjustments For Finance Costs 12 month as first filed |
|---|---|---|
| 2022-12-31 | $28.00K 20-F · filed 2023-05-02 | |
| 2021-12-31 | $20.00K 20-F · filed 2023-05-02 | |
| 2020-12-31 | $30.00K 20-F · filed 2023-05-02 | |
| 2019-12-31 | $18.00K 20-F · filed 2022-03-30 | -$18.00K 20-F · filed 2020-03-30 |
| 2018-12-31 | $18.00K 20-F · filed 2021-03-29 | -$18.00K 20-F · filed 2019-03-29 |
| 2017-12-31 | -$204.00K 20-F · filed 2020-03-30 | |
| 2016-12-31 | -$244.00K 20-F · filed 2019-03-29 |